EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB)

被引：0

作者：

Schwarz, Kathleen B. ^{[1
]}

Bezerra, Jorge A. ^{[2
]}

Choe, Byung Ho ^{[3
,4
]}

Lin, Chuan-Hao ^{[5
]}

Abramov, Frida ^{[6
]}

Wang, Hongyuan ^{[6
]}

Liu, Yang ^{[6
]}

Flaherty, John F. ^{[6
]}

Pacurar, Daniela ^{[7
]}

Kim, Kyung Mo ^{[8
]}

Khaertynova, Ilsiyar ^{[9
]}

Shalimar ^{[10
]}

Wu, Jia-Feng ^{[11
]}

Tandon, Manish ^{[12
]}

Rosenthal, Philip ^{[13
]}

Morozov, Viacheslav ^{[14
]}

Sokal, Etienne M. ^{[15
]}

Chang, Mei Hwei ^{[16
,17
]}

机构：

[1] Univ Calif San Diego, Rady Childrens Hosp San Diego, San Diego, CA 92103 USA

[2] Univ Texas Southwestern Med Ctr, Dallas, TX USA

[3] Kyungpook Natl Univ, Sch Med, Daegu, South Korea

[4] Kyungpook Natl Univ Childrens Hosp, Daegu, South Korea

[5] Childrens Hosp Los Angeles, Los Angeles, CA USA

[6] Gilead Sci Inc, Foster City, CA USA

[7] Carol Davila Univ Med & Pharm, Bucharest, Romania

[8] Univ Ulsan, Asan Med Ctr, Childrens Hosp, Seoul, South Korea

[9] Kazan State Med Univ, Kazan, Russia

[10] All India Inst Med Sci, Delhi, India

[11] Natl Taiwan Univ Hosp, Taipei, Taiwan

[12] MV Hosp & Res Ctr, Lucknow, Uttar Pradesh, India

[13] Univ Calif San Francisco, San Francisco, CA 94143 USA

[14] Hepatolog Med Co, Samara, Russia

[15] Clin Univ St Luc, Brussels, Belgium

[16] Natl Taiwan Univ, Taipei, Taiwan

[17] Children Hosp, Taipei, Taiwan

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1414C

引用

页码：S515 / S517

页数：3

共 50 条

[41] Tenofovir Alafenamide: A Review in Chronic Hepatitis B
Lesley J. Scott
Henry L. Y. Chan
Drugs, 2017, 77 : 1017 - 1028
[42] Three Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B
Chan, Henry Lik Yuen
Lim, Young-Suk
Seto, Wai Kay Walter
Agarwal, Kosh
Brunetto, Maurizia R.
Janssen, Harry L. A.
Caruntu, Florin
Stepanova, Tatjana
Tsang, Owen
Yatsuhashi, Hiroshi
Tak, Won Young
Chen, Chi-Yi
Celen, Mustafa
Suri, Vithika
Flaherty, John F.
Lin, Lanjia
Cathcart, Andrea
Gaggar, Anuj
Pan, Calvin Q.
Shalimar
Buti, Maria
HEPATOLOGY, 2018, 68 : 227A - 228A
[43] SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) AND/OR OTHER ORAL ANTIVIRALS (OAVS) TO TENOFOVIR ALAFENAMIDE (TAF) IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B (CHB) PATIENTS WITH HEPATIC IMPAIRMENT: FINAL 2-YEAR EFFICACY AND SAFETY RESULTS FROM A PHASE 2
Lim, Young-Suk
Lin, Chun-Yen
Heo, Jeong
Bae, Ho
Chuang, Wan-Long
Yin, Tak
Tsang, Owen
Fournier, Claire
Hui, Aric Josun
Trinh, Huy
Chan, Carol Yee Kwan
Tan, Susanna K.
Zhao, Yang
Flaherty, John F.
Suri, Vithika
Gaggar, Anuj
Brainard, Dianna M.
Ryder, Stephen
La Janssen, Harry
GUT, 2021, 70 : A77 - A77
[44] Tenofovir Alafenamide: A Review in Chronic Hepatitis B
Scott, Lesley J.
Chan, Henry L. Y.
DRUGS, 2017, 77 (09) : 1017 - 1028
[45] A PHASE 3 STUDY COMPARING SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) WITH CONTINUED TDF TREATMENT IN VIROLOGICALLY-SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B (CHB): WEEK 48 EFFICACY AND SAFETY RESULTS
Chan, Henry Lik Yuen
Lampertico, Pietro
Buti, Maria
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Tak, Won Young
Ramji, Alnoor
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Flaherty, John
Gaggar, Anuj
Lau, Audrey
Feierbach, Becket
Wu, George
Suri, Vithika
Subramanian, Mani
Huy Trinh
Yoon, Seung-Kew
Agarwal, Kosh
Lim, Young-Suk
GUT, 2019, 68 : A142 - A143
[46] SAFETY AND EFFICACY OF TENOFOVIR ALAFENAMIDE FUMARATE USED DURING WHOLE PREGNANCY IN WOMEN WITH CHRONIC HEPATITIS B
Xie, Yao
Yi, Wei
HEPATOLOGY, 2021, 74 : 515A - 516A
[47] Safety and Efficacy of Tenofovir Alafenamide Fumarate in Early-Middle Pregnancy for Mothers With Chronic Hepatitis B
Chen, Ruochan
Zou, Ju
Long, Liyuan
Huang, Haiyue
Zhang, Min
Fan, Xuegong
Huang, Yan
FRONTIERS IN MEDICINE, 2022, 8
[48] A phase 3 study of tenofovir alafenamide (TAF) compared with tenofovir disoproxil fumarate (TDF) in patients with HBeAg-positive chronic HBV (CHB): Week 48 efficacy and safety results
Strasser, S.
Roberts, S.
Angus, P.
Chan, H. L. Y.
Fung, S.
Seto, W. K.
Chuang, W. L.
Chen, C. Y.
Kim, H. J.
Hui, A. J.
Janssen, H. L. A.
Chowdhury, A.
Tsang, T. Y. O.
Mehta, R.
Gane, E.
Flaherty, J. F.
Massetto, B.
Kitrinos, K.
Dinh, P.
Subramanian, G. M.
Mchutchison, J. G.
Lim, Y. S.
Acharya, S. K.
Agarwal, K.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 82 - 82
[49] HERACLIS-TAF: a multicentre prospective cohort study on 2-year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risks
Papatheodoridis, George, V
Mimidis, Kostas
Manolakopoulos, Spilios
Gatselis, Nikolaos
Goulis, John
Kapatais, Andreas
Manesis, Emanuel
Vasiliadis, Themistoklis
Triantos, Christos
Samonakis, Dimitrios
Sevastianos, Vasilios
Karatapanis, Stelios
Elefsiniotis, Ioannis
Deutsch, Melanie
Mylopoulou, Theodora
Papatheodoridi, Margarita
Kranidioti, Hariklia
Agorastou, Polyxeni
Karaoulani, Theofani
Kyriazidou, Anastasia
Zisimopoulos, Konstantinos
Dalekos, George N.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (04) : 702 - 712
[50] Two-year safety and efficacy of tenofovir alafenamide in chronic hepatitis B: a HEllenic multicenter ReAl-life CLInical Study (HERACLIS-TAF)
Papatheodoridis, George
Mimidis, Konstantinos
Manolakopoulos, Spilios
Gatselis, Nikolaos
Goulis, Ioannis
Kapatais, Andreas
Manesis, Emmanouil
Vasileiadis, Themistoklis
Triantos, Christos
Samonakis, Demetrious N.
Sevastianos, Vasilis
Karapatanis, Stylianos
Elefsiniotis, Ioannis
Deutsch, Melanie
Mylopoulou, Theodora
Papatheodoridi, Margarita
Kranidioti, Hariklia
Agorastou, Polyxeni
Karaoulani, Theofanie
Kyriazidou, Anastasia
Zisimopoulos, Konstanitnos
Dalekos, George
JOURNAL OF HEPATOLOGY, 2022, 77 : S840 - S841

← 1 2 3 4 5 →